TheEdgeResearch
Home / Stocks / CLOV

Clover Health Investments, Corp. (CLOV)

NASDAQ Healthcare Medical - Healthcare Plans
$4.51 ▲ +2.73%
Market Cap
$2.34B
Sector
Healthcare
Industry
Medical - Healthcare Plans
Beta
2.48
52-Wk Range
1.58-5.59
CEO
Andrew Toy
Country
US
Currency
USD

Clover Health Investments, Corp. operates in the Medical - Healthcare Plans industry of the Healthcare sector, headquartered in Wilmington, DE, US. The stock last traded at $4.51, up 2.73% on the session, giving a market capitalisation of $2.34B. On trailing twelve-month figures it carries a trailing P/E of -111.36, a net margin of -0.7%. Its beta of 2.48 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-111.36
Price / Sales
0.94
Price / Book
6.28
EV / EBITDA
-129.94
Gross margin
18.6%
Operating margin
-0.7%
Net margin
-0.7%
Return on equity
Debt / equity
0.00
Current ratio
1.50
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Select
Employees
724
IPO date
2020-06-12
Headquarters
Wilmington, DE, US
About Clover Health Investments, Corp.

Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.

Comparable companies

Clover Health Investments, Corp. is most often compared with the following Healthcare names:

BGMCERTGPCRGRDNLFSTNHCPRCTQDELTWSTTXG
More research on CLOV
CLOV technical analysis CLOV TheEdge Score Compare against peers
Open full interactive analysis & DCF →